Metabolic derangement of methionine and folate metabolism in mice deficient in methionine synthase reductase

Molecular Genetics and Metabolism - Tập 91 - Trang 85-97 - 2007
C. Lee Elmore1, Xuchu Wu2, Daniel Leclerc3, Erica D. Watson2, Teodoro Bottiglieri4, Natalia I. Krupenko5, Sergey A. Krupenko5, James C. Cross2, Rima Rozen3, Roy A. Gravel2, Rowena G. Matthews1
1Life Sciences Institute, University of Michigan, Ann Arbor, MI, USA
2Department of Biochemistry and Molecular Biology, University of Calgary, Calgary, Alta., Canada
3Departments of Human Genetics and Pediatrics, McGill University—Montreal Children’s Hospital, Montreal, Que., Canada
4Institute of Metabolic Disease, Baylor University Medical Center, Dallas, TX, USA
5Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC USA

Tài liệu tham khảo

Olteanu, 2001, Human methionine synthase reductase, a soluble P-450 reductase-like dual flavoprotein, is sufficient for NADPH-dependent methionine synthase activation, J. Biol. Chem., 276, 35558, 10.1074/jbc.M103707200 Gulati, 1997, Defects in auxiliary redox proteins lead to functional methionine synthase deficiency, J. Biol. Chem., 272, 19171, 10.1074/jbc.272.31.19171 Jencks, 1987, Allosteric inhibition of methylenetetrahydrofolate reductase by adenosylmethionine. Effects of adenosylmethionine and NADPH on the equilibrium between active and inactive forms of the enzyme and on the kinetics of approach to equilibrium, J. Biol. Chem., 262, 2485, 10.1016/S0021-9258(18)61530-3 Kutzbach, 1971, Mammalian methylenetetrahydrofolate reductase. Partial purification, properties, and inhibition by S-adenosylmethionine, Biochim. Biophys. Acta, 250, 459, 10.1016/0005-2744(71)90247-6 Smulders, 2006, Cellular folate vitamer distribution during and after correction of vitamin B12 deficiency: a case for the methylfolate trap, Br. J. Haematol., 132, 623, 10.1111/j.1365-2141.2005.05913.x Koury, 1997, Apoptosis of late-stage erythroblasts in megaloblastic anemia: association with DNA damage and macrocyte production, Blood, 89, 4617, 10.1182/blood.V89.12.4617 Koury, 2000, Apoptosis in megaloblastic anemia occurs during DNA synthesis by a p53-independent, nucleoside-reversible mechanism, Blood, 96, 3249, 10.1182/blood.V96.9.3249 Swanson, 2001, Targeted disruption of the methionine synthase gene in mice, Mol. Cell. Biol., 21, 1058, 10.1128/MCB.21.4.1058-1065.2001 Drummond, 1993, Assignment of enzymic function to specific protein regions of cobalamin-dependent methionine synthase from Escherichia coli, Biochemistry, 32, 9290, 10.1021/bi00087a005 Fujii, 1977, Activation of methionine synthase: further characterization of flavoprotein system, Arch. Biochem. Biophys., 178, 662, 10.1016/0003-9861(77)90238-7 Banerjee, 1990, Mechanism of reductive activation of cobalamin-dependent methionine synthase: an electron paramagnetic resonance spectroelectrochemical study, Biochemistry, 29, 1129, 10.1021/bi00457a005 Porter, 1986, NADPH-cytochrome P-450 oxidoreductase: flavin mononucleotide and flavin adenine dinucleotide domains evolved from different flavoproteins, Biochemistry, 25, 1682, 10.1021/bi00355a036 Fujii, 1974, Activation of methionine synthetase by a reduced triphosphopyridine nucleotide-dependent flavoprotein system, J. Biol. Chem., 249, 6745, 10.1016/S0021-9258(19)42122-4 Osborne, 1991, Isolation, cloning, mapping, and nucleotide sequencing of the gene encoding flavodoxin in Escherichia coli, J. Bacteriol., 173, 1729, 10.1128/jb.173.5.1729-1737.1991 Olteanu, 2003, Redundancy in the pathway for redox regulation of mammalian methionine synthase: reductive activation by the dual flavoprotein, novel reductase 1, J. Biol. Chem., 278, 38310, 10.1074/jbc.M306282200 Rosenblatt, 1990, Inherited disorders of vitamin B12 utilization, Bioessays, 12, 331, 10.1002/bies.950120705 Raff, 1991, Genetic characterization of a MUT locus mutation discriminating heterogeneity in mut0 and mut-methylmalonic aciduria by interallelic complementation, J. Clin. Invest., 87, 203, 10.1172/JCI114972 Watkins, 2000, Complementation studies in the cblA class of inborn error of cobalamin metabolism: evidence for interallelic complementation and for a new complementation class (cblH), J. Med. Genet., 37, 510, 10.1136/jmg.37.7.510 Wilson, 1999, Molecular basis for methionine synthase reductase deficiency in patients belonging to the cblE complementation group of disorders in folate/cobalamin metabolism, Hum. Mol. Genet., 8, 2009, 10.1093/hmg/8.11.2009 Leclerc, 1998, Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria, Proc. Natl. Acad. Sci. USA, 95, 3059, 10.1073/pnas.95.6.3059 Rosenblatt, 1984, Altered vitamin B12 metabolism in fibroblasts from a patient with megaloblastic anemia and homocystinuria due to a new defect in methionine biosynthesis, J. Clin. Invest., 74, 2149, 10.1172/JCI111641 Watkins, 1988, Genetic heterogeneity among patients with methylcobalamin deficiency. Definition of two complementation groups, cblE and cblG, J. Clin. Invest., 81, 1690, 10.1172/JCI113507 Steen, 1997, Cobalamin E (cblE) disease: a severe neurological disorder with megaloblastic anaemia, homocystinuria and low serum methionine, J. Inherit. Metab. Dis., 20, 705, 10.1023/A:1005382627986 Fowler, 1997, Folate-responsive homocystinuria and megaloblastic anaemia in a female patient with functional methionine synthase deficiency (cblE disease), J. Inherit. Metab. Dis., 20, 731, 10.1023/A:1005372730310 Zavadakova, 2005, cblE type of homocystinuria due to methionine synthase reductase deficiency: functional correction by minigene expression, Hum. Mutat., 25, 239, 10.1002/humu.20131 Chen, 2001, Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition, Hum. Mol. Genet., 10, 433, 10.1093/hmg/10.5.433 Dayal, 2001, Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine beta-synthase-deficient mice, Circ. Res., 88, 1203, 10.1161/hh1101.092180 Yamada, 2006, Human methionine synthase reductase is a molecular chaperone for human methionine synthase, Proc. Natl. Acad. Sci. USA, 103, 9476, 10.1073/pnas.0603694103 Ubbink, 1991, Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum, J. Chromatogr., 565, 441, 10.1016/0378-4347(91)80407-4 Bottiglieri, 1990, Isocratic high performance liquid chromatographic analysis of S-adenosylmethionine and S-adenosylhomocysteine in animal tissues: the effect of exposure to nitrous oxide, Biomed. Chromatogr., 4, 239, 10.1002/bmc.1130040606 Priest, 1991, Pharmacokinetics of leucovorin metabolites in human plasma as a function of dose administered orally and intravenously, J. Natl. Cancer Inst., 83, 1806, 10.1093/jnci/83.24.1806 Kawata, 1995, Utilization of dietary protein in the vitamin B12-deficient rats, Int. J. Vitam. Nutr. Res., 65, 248 Wilson, 1999, A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida, Mol. Genet. Metab., 67, 317, 10.1006/mgme.1999.2879 Doolin, 2002, Maternal genetic effects, exerted by genes involved in homocysteine remethylation, influence the risk of spina bifida, Am. J. Hum. Genet., 71, 1222, 10.1086/344209 Zhu, 2003, Homocysteine remethylation enzyme polymorphisms and increased risks for neural tube defects, Mol. Genet. Metab., 78, 216, 10.1016/S1096-7192(03)00008-8 Gueant-Rodriguez, 2003, Transcobalamin and methionine synthase reductase mutated polymorphisms aggravate the risk of neural tube defects in humans, Neurosci. Lett., 344, 189, 10.1016/S0304-3940(03)00468-3 Relton, 2004, Gene-gene interaction in folate-related genes and risk of neural tube defects in a UK population, J. Med. Genet., 41, 256, 10.1136/jmg.2003.010694 Copp, 2003, The genetic basis of mammalian neurulation, Nat. Rev. Genet., 4, 784, 10.1038/nrg1181 Gossler, 1989, Mouse embryonic stem cells and reporter constructs to detect developmentally regulated genes, Science, 244, 463, 10.1126/science.2497519 Voss, 1998, Compensation for a gene trap mutation in the murine microtubule-associated protein 4 locus by alternative polyadenylation and alternative splicing, Dev. Dyn., 212, 258, 10.1002/(SICI)1097-0177(199806)212:2<258::AID-AJA10>3.0.CO;2-0 Li, 2005, Myocardin-related transcription factor B is required in cardiac neural crest for smooth muscle differentiation and cardiovascular development, Proc. Natl. Acad. Sci. USA, 102, 8916, 10.1073/pnas.0503741102 Galy, 2004, Targeted mutagenesis of the murine IRP1 and IRP2 genes reveals context-dependent RNA processing differences in vivo, RNA, 10, 1019, 10.1261/rna.7220704 Dayal, 2005, Cerebral vascular dysfunction in methionine synthase-deficient mice, Circulation, 112, 737, 10.1161/CIRCULATIONAHA.104.529248 J.W. Miller, The pathogenesis of homocysteinemia due to B vitamin deficiencies, Ph.D. Thesis, Tufts University, Boston, 1993. Luka, 2006, A glycine N-methyltransferase knockout mouse model for humans with deficiency of this enzyme, Transgenic Res., 15, 393, 10.1007/s11248-006-0008-1 Yeo, 1994, Tissue distribution of glycine N-methyltransferase, a major folate-binding protein of liver, Proc. Natl. Acad. Sci. USA, 91, 210, 10.1073/pnas.91.1.210 Kerr, 1972, Competing methyltransferase systems, J. Biol. Chem., 247, 4248, 10.1016/S0021-9258(19)45067-9 Centers for Disease Control, 1991, Use of folic acid for prevention of spina bifida and other neural tube defects—1983–1991, Morb. Mortal. Wkly. Rep., 40, 513 MRC Vitamin Study Research Group, 1991, Prevention of neural tube defects: results of the Medical Research Council Vitamin Study, Lancet, 338, 131, 10.1016/0140-6736(91)90133-A Blom, 2006, Neural tube defects and folate: case far from closed, Nat. Rev. Neurosci., 7, 724, 10.1038/nrn1986 Boushey, 1995, A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes, JAMA, 274, 1049, 10.1001/jama.1995.03530130055028 Bostom, 1999, Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study, Ann. Intern. Med., 131, 352, 10.7326/0003-4819-131-5-199909070-00006 Clarke, 1991, Hyperhomocysteinemia: an independent risk factor for vascular disease, N. Engl. J. Med., 324, 1149, 10.1056/NEJM199104253241701 McCully, 1969, Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis, Am. J. Pathol., 56, 111 Selhub, 1995, Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis, N. Engl. J. Med., 332, 286, 10.1056/NEJM199502023320502 Watanabe, 1995, Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia, Proc. Natl. Acad. Sci. USA, 92, 1585, 10.1073/pnas.92.5.1585